Cargando…

Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment

The aim of this study was to assess the prognostic and predictive value of an untargeted assessment of tumor fractions in the plasma of metastatic breast cancer patients and to compare circulating tumor DNA (ctDNA) with circulating tumor cells (CTC) and conventional tumor markers. In metastatic brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suppan, Christoph, Brcic, Iva, Tiran, Verena, Mueller, Hannah D, Posch, Florian, Auer, Martina, Ercan, Erkan, Ulz, Peter, Cote, Richard J, Datar, Ram H, Dandachi, Nadia, Heitzer, Ellen, Balic, Marija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721524/ https://www.ncbi.nlm.nih.gov/pubmed/31416207 http://dx.doi.org/10.3390/cancers11081171

Ejemplares similares

Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients
por: Benezeder, Theresa, et al.
Publicado: (2017)

Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR(+) breast cancer patients undergoing CDK4/6 treatment
por: Dandachi, Nadia, et al.
Publicado: (2020)

Genetic and epigenetic analysis of putative breast cancer stem cell models
por: Balic, Marija, et al.
Publicado: (2013)

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition
por: Tiran, Verena, et al.
Publicado: (2017)

Genetic profiling of putative breast cancer stem cells from malignant pleural effusions
por: Tiran, Verena, et al.
Publicado: (2017)

Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression
por: Brcic, Iva, et al.
Publicado: (2023)

Deciphering the molecular landscape of metastatic lobular breast cancer
por: Dandachi, Nadia, et al.
Publicado: (2022)

Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
por: Müller, Hannah Deborah, et al.
Publicado: (2019)

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
por: Suppan, Christoph, et al.
Publicado: (2015)

Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity
por: Suppan, Christoph, et al.
Publicado: (2021)

Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013)

Single circulating tumor cell sequencing for monitoring
por: Auer, Martina, et al.
Publicado: (2013)

Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype
por: Čipak Gašparović, Ana, et al.
Publicado: (2019)

Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016
por: Suppan, Christoph, et al.
Publicado: (2017)

It is time to prepare for D-CARE!
por: Suppan, Christoph, et al.
Publicado: (2020)

Hazard Curves for Tumor Recurrence and Tumor-Related Death Following Esophagectomy for Esophageal Cancer
por: Lindenmann, Joerg, et al.
Publicado: (2020)

Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer
por: Perakis, Samantha O, et al.
Publicado: (2020)

Molecular profiling of soft-tissue sarcomas with FoundationOne(®) Heme identifies potential targets for sarcoma therapy: a single-centre experience
por: Scheipl, Susanne, et al.
Publicado: (2021)

Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
por: Mohan, Sumitra, et al.
Publicado: (2014)

The dynamic range of circulating tumor DNA in metastatic breast cancer
por: Heidary, Maryam, et al.
Publicado: (2014)

Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
por: Posch, Florian, et al.
Publicado: (2022)

Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
por: Ulz, Peter, et al.
Publicado: (2016)

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
por: Zhou, Qing, et al.
Publicado: (2022)

β‐catenin regulates FOXP2 transcriptional activity via multiple binding sites
por: Richter, Gesa, et al.
Publicado: (2020)

St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer
por: Thomssen, Christoph, et al.
Publicado: (2021)

Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma
por: Heitzer, Ellen, et al.
Publicado: (2013)

Untargeted muscle tissue metabolites profiling in young, adult, and old rats supplemented with tocotrienol-rich fraction
por: Saud Gany, Siti Liyana, et al.
Publicado: (2022)

Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study
por: Markoš, Pave, et al.
Publicado: (2018)

Untargeted Metabolomics Combined with Solid Phase Fractionation for Systematic Characterization of Bioactive Compounds in Hemp with Methane Mitigation Potential
por: Jensen, Rikke Hald, et al.
Publicado: (2022)

Erratum: Untargeted muscle tissue metabolites profiling in young, adult, and old rats supplemented with tocotrienol-rich fraction
por: Frontiers Production Office,
Publicado: (2022)

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
por: Heitzer, Ellen, et al.
Publicado: (2013)

Generalizations of incompressible and compressible Navier–Stokes equations to fractional time and multi-fractional space
por: Kavvas, M. Levent, et al.
Publicado: (2022)

Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
por: Strohmeier, Simon, et al.
Publicado: (2021)

Automated Sequential Analysis of Hydrophilic and Lipophilic Fractions of Biological Samples: Increasing Single-Injection Chemical Coverage in Untargeted Metabolomics
por: Pirttilä, Kristian, et al.
Publicado: (2021)

Protective effects of Descurainia sophia seeds extract and its fractions on pulmonary edema by untargeted urine and serum metabolomics strategy
por: Zhang, Jinying, et al.
Publicado: (2023)

Faba Bean (Vicia faba L. minor) Bitterness: An Untargeted Metabolomic Approach to Highlight the Impact of the Non-Volatile Fraction
por: Karolkowski, Adeline, et al.
Publicado: (2023)

Update on Molecular Genetics of Gastrointestinal Stromal Tumors
por: Brčić, Iva, et al.
Publicado: (2021)

Targeting the untargetable KRAS in cancer therapy
por: Liu, Pingyu, et al.
Publicado: (2019)

Untargeted Metabolomic Characterization of Ovarian Tumors
por: Liu, Xiaona, et al.
Publicado: (2020)

Editorial: Advances and challenges in untargeted metabolomics
por: Wawrzyniak, Renata, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9g18f0vrtsfqd84l816cbns2ks